￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Entrectinib has long-term clinical efficacy in ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
[Clinical Observation] Xakori (crizotinib) is effective in ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Will the lung cancer targeted drug Gitare be reimbursed by medical insurance? If you want to know, hurry up

2025-10-19 11:44:20

Check Details
What is the out-of-pocket rate for Gyterinib (afatinib)? Everything everyone cares about is here

2025-10-19 11:44:20

Check Details
[New Social Security Regulations] How much can Gefitinib save after medical insurance in 2021?

2025-10-19 11:44:20

Check Details
Will the targeted drug afatinib be reimbursed by medical insurance? List of targeted drugs reimbursed by medical insurance

2025-10-19 11:44:20

Check Details
The greater the side effects of the targeted drug gefitinib, the better the effect? Oncology experts see it this way

2025-10-19 11:44:20

Check Details
How much does a box of Cabozantinib cost? Where can I buy it?

2025-10-19 11:44:20

Check Details
What is the price advantage of Giteri (afatinib) after it is included in medical insurance? Where to buy discounts?

2025-10-19 11:44:20

Check Details
[What you are most concerned about] Will taking the targeted drug gefitinib for three months make the tumor disappear?

2025-10-19 11:44:20

Check Details
A new treatment option for patients with RET-rearranged lung cancer - Cabozantinib

2025-10-19 11:44:20

Check Details
[Know early on reimbursement] Medical insurance conditions and prices of Giteri (afatinib) in 2021

2025-10-19 11:44:20

Check Details
Category
相关知识